A world where every cure is possible.
Aldevron stands at the forefront of Biotechnology Research, dedicated to a world where every cure is possible. As a key part of Danaher, Aldevron leverages unparalleled science and technology to deliver cutting-edge solutions, impacting countless lives through advancements in biotechnology, diagnostics, and life sciences.
Located at its primary address at 4055 41st Ave S, Fargo, North Dakota 58104, US, and with additional locations including 5602 Research Park Blvd, Suite 112, Madison, Wisconsin 53719, US, and 3100 University Dr S, Fargo, North Dakota 58103, US, Aldevron is committed to unlocking transformative potential in gene therapy, cell therapy, and vaccine development. Aldevron specializes in Plasmid DNA, Messenger RNA (mRNA), Recombinant Proteins, and CRISPR/Cas9, operating under cGMP and GMP-Source standards to ensure the highest quality and reliability.
Aldevron continues to innovate and expand its capabilities, contributing significantly to the global biotechnology landscape. Aldevron aims to further enhance its services and solutions with the ongoing support of its dedicated management team. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to highlight Aldevron's exceptional offerings.
Aldevron est à l'avant-garde de la recherche biotechnologique, dédiée à un monde où chaque guérison est possible. En tant qu'élément clé de Danaher, Aldevron tire parti d'une science et d'une technologie inégalées pour fournir des solutions de pointe, ayant un impact sur d'innombrables vies grâce aux progrès de la biotechnologie, des diagnostics et des sciences de la vie.
Située à son adresse principale au 4055 41st Ave S, Fargo, North Dakota 58104, US, et avec des emplacements supplémentaires, notamment au 5602 Research Park Blvd, Suite 112, Madison, Wisconsin 53719, US, et au 3100 University Dr S, Fargo, North Dakota 58103, US, Aldevron s'engage à libérer le potentiel de transformation de la thérapie génique, de la thérapie cellulaire et du développement de vaccins. Aldevron est spécialisée dans l'ADN plasmidique, l'ARN messager (ARNm), les protéines recombinantes et CRISPR/Cas9, opérant selon les normes cGMP et GMP-Source pour garantir la plus haute qualité et fiabilité.
Aldevron continue d'innover et d'étendre ses capacités, contribuant de manière significative au paysage mondial de la biotechnologie. Aldevron vise à améliorer encore ses services et solutions avec le soutien continu de son équipe de direction dévouée. Nous invitons l'équipe de direction à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en valeur les offres exceptionnelles d'Aldevron.
Compare Aldevron with 3 companies in Biotechnology-Research
| Comparison Field |
AldevronMain Company |
CRISPR Medicine NewsView Profile |
MaxCyte, Inc.View Profile |
Poseida Therapeutics...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2019 | 1999 | 2014 |
|
Company Size
|
— | 2-10 | 51-200 | 201-500 |
|
City
|
Fargo, North Dakota | Rockville, Maryland | San Diego, California | |
|
Country
|
United States | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Biotechnology
Plasmid DNA
mRNA
Recombinant Proteins
Gene Therapy
Cell Therapy
Vaccine Development
Messenger RNA (mRNA)
CRISPR/Cas9
cGMP
GMP-Source
Gene Editing
|
7 Total
7 Unique
Unique Skills:
clinical trials
CRISPR
Genetic medicine
Interviews
Media
Medicine
+1
|
17 Total
1 Common
16 Unique
Match
8%
Common Skills:
Biotechnology
Unique Skills:
Bispecifics
Cancer
Cancer Research
CARMA
Cell Engineering
Electroporation
+10
|
21 Total
1 Common
20 Unique
Match
8%
Common Skills:
Biotechnology
Unique Skills:
Adoptive Cell Therapy
Allogeneic
CAR-T cells
Cas-CLOVER™
Cytotoxic T Lymphocytes
Genome Engineering
+14
|
Other organizations in the same industry
This company is also known as